Topics
- Research Activities
April 8, 2024
- Press Releases
Itabashi CampusA research group led by Professor Suzuki of the Faculty of Pharma-Science has developed a new polymer-bound anticancer drug.
On Monday, April 8, 2024, Professor Ryo Suzuki of the Department Faculty of Pharma-Science Delivery Science, Faculty of Pharmaceutical Sciences, Teikyo University, in a non-clinical study conducted in collaboration with Toray Industries, Inc. and Professor Yasuhito Uezono of the Department of Pain Control Research, Jikei University School of Medicine, confirmed that a polymer-bound anticancer drug (code name: TXB-001) exhibits strong anticancer effects against multiple types of solid cancers and significantly reduces multiple toxicities, including cardiotoxicity, observed in existing anthracycline anticancer drugs.
Read the press release here
For more information on Professor Suzuki's research at Teikyo Lab, please click here
For more information about Professor Suzuki, click here
For more information about the Teikyo University Faculty of Pharma-Science Drug Delivery Laboratory, click here